The “Intelligent Trials” technology focuses on the feasibility of studies, and providing diversity data to aid companies in meeting representative enrollment targets.
Read More
On a hot Thursday afternoon in August, Velocity staff was celebrating the opening of its most recent site in Durham by sponsoring a back-to-school event at Eastway Elementary School.
Read More
Clinetic, a Duke University spinout focused on linking hospital data with clinical studies, has created a platform that makes it possible for researchers to use data from hospital electronic health records (EHRs) to improve patient recruitment for clinical trials as well as gain more insights into the data.
Read More
Clinetic, a life science startup focusing on patient recruitment for clinical trials and related data, says it has closed its Series A funding round with the backing of Sopris Capital. Here are the details.
Read More
Duke Clinical Research Institute and Protas, a not-for-profit clinical trials organization based in the United Kingdom, have launched a long-term collaboration to transform clinical research by altering the way clinical trials are designed and delivered to better meet the needs of patients and society.
Read More
Velocity Clinical should incorporate “High” into its name as in “high velocity growth” after the Durham-based firm announced the latest – and largest – acquisition to date early Thursday.
Read More
Relentless, early and often data collection and insight generation allowed BioCryst to anticipate and strategically leverage information for the good of patients — a true competitive advantage and foundation for company success.
Read More
Science 37, Inc., a life science company focusing on clinical trials, is moving its headquarters to Morrisville from Culver City, Calif. and bringing along with it some 250 jobs paying an average minimum wage of more than $114,000.
Read More
Clinical Trials first appeared in 1747, and in the 274 years since then, they have progressed exponentially in terms of technology. Here’s a look at the history.
Read More
